CLARITY MEDICAL(01406): XU Anliang appointed as independent non-executive director and member of the audit committee.
Qingxi Medical (01406) announced that Mr. Xu Anliang has been appointed by the Board of Directors as an independent non-executive director and a member of the Company Review Committee, effective from January 22, 2026. Mr. Sun Peng has been appointed by the Board of Directors as a non-executive director, effective from January 22, 2026.
CLARITY MEDICAL (01406) announcement: Mr. Xu Anliang has been appointed as an independent non-executive director and member of the company's audit committee by the board of directors, effective from January 22, 2026. Mr. Sun Peng has been appointed as a non-executive director by the board of directors, effective from January 22, 2026.
Related Articles
LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.
LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.
MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.
LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.
LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.
MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026
